ALCOX:EPA
NicOx SA
0,29 €
arrow_downward
-1,03%(-0,0030) 1D
13. nov., 17.35.02 GMT+1 · EUR
search
Alle symboler
| Symbol | Pris | Ændring | Ændring i % |
|---|
insights_autoGenererer vigtig indsigt for ALCOX...
Åbn
0,30 €
Høj
0,30 €
Lav
0,29 €
Markedsværdi
28,14 mio.
Gns. vol.
134,07 t
Volumen
82,75 t
P/E-forhold
4,97
Højeste i 52 uger
0,57 €
Laveste i 52 uger
0,28 €
Indtægt pr. aktie
0,06 €
Aktier i omløb
99,07 mio.
Antal ansatte
5
Åbn
0,30 €
Høj
0,30 €
Lav
0,29 €
Markedsværdi
28,14 mio.
Gns. vol.
134,07 t
Volumen
82,75 t
P/E-forhold
4,97
Højeste i 52 uger
0,57 €
Laveste i 52 uger
0,28 €
Indtægt pr. aktie
0,06 €
Aktier i omløb
99,07 mio.
Antal ansatte
5
Nyhedshistorier
Fra webkilder og nyhedspartnere
BigGo Finance
·
for 5 timer siden
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
The Motley Fool
·
for 4 timer siden
Tesla Is Down 13% in 2026 While the S&P 500 Is Up. Here’s the 1 Catalyst Left This Year That Could Flip That.
24/7 Wall St.
·
for 3 timer siden
Gilead Beat the S&P 500 by More Than 25 Points in the Past Year, but $1,000 From a Decade Ago Is Still Worth Less Than $3,500
Traders Union
·
for 3 timer siden
Chris Ciovacco: Semiconductors SMH and S&P 500 SPY show several possible support areas
Profil
Nicox S.A. is a French ophthalmology company developing treatments to maintain vision and improve ocular health. Nicox is headquartered in Sophia Antipolis, France, and its Chairman and CEO is Michele Garufi.
Nicox is listed on Euronext Paris and is part of the CAC Healthcare, CAC Pharma & Bio and Next 150 indexes. Its pipeline includes three programs in development, and it has two U.S. Food and Drug Administration approved products. Wikipedia
Om NicOx SA
Administrerende direktør-
Ansatte5
Grundlagt1996
HovedsædeValbonne, Provence-Alpes-Côte d'Azur, Frankrig
SektorHealth Care
Branche-
Websitenicox.com